Zhiping Li

Active 2000–2025

269
Papers
25,449
Citations
85
h-index
219
i10-index

Citations

Citations per year for Zhiping Li1988: 1 citations1990: 1 citations1991: 1 citations1993: 1 citations1996: 1 citations2000: 1 citations2001: 3 citations2003: 19 citations2004: 53 citations2005: 81 citations2006: 145 citations2007: 116 citations2008: 203 citations2009: 219 citations2010: 261 citations2011: 262 citations2012: 236 citations2013: 265 citations2014: 152 citations2015: 151 citations2016: 133 citations2017: 116 citations2018: 157 citations2019: 523 citations2020: 614 citations2021: 714 citations2022: 662 citations2023: 616 citations2024: 945 citations2025: 501 citations2026: 19 citations1989: no citations, so this year is not shown1992: no citations, so this year is not shown1994–1995: no citations, so these years are not shown1997–1999: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,418 citing papers, 28.7% of this breakdownUnited States: 1,575 citing papers, 18.7% of this breakdownUnited Kingdom: 342 citing papers, 4.1% of this breakdownIndia: 289 citing papers, 3.4% of this breakdownGermany: 286 citing papers, 3.4% of this breakdownItaly: 275 citing papers, 3.3% of this breakdownJapan: 213 citing papers, 2.5% of this breakdownCanada: 202 citing papers, 2.4% of this breakdownSouth Korea: 193 citing papers, 2.3% of this breakdownFrance: 190 citing papers, 2.3% of this breakdownSpain: 186 citing papers, 2.2% of this breakdownIran: 184 citing papers, 2.2% of this breakdown
0%28.7%Other 24.5%

Fields

  • Medicine43.3%
  • Biochemistry, Genetics and Molecular Biology25%
  • Chemistry7%
  • Engineering5.1%
  • Immunology and Microbiology3.5%
  • Materials Science3.3%
  • Other12.8%

Topics

  • Liver Disease Diagnosis and Treatment4.2%
  • MicroRNA in disease regulation1.8%
  • Catalytic C–H Functionalization Methods1.8%
  • Gut microbiota and health1.6%
  • Nanoparticle-Based Drug Delivery1.4%
  • RNA Interference and Gene Delivery1.4%
  • Other87.8%

Coauthors

All papers

Open in search
  1. PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

    Authors: , , , , , , , , , , , - Ageing Research Reviews 2022 cited by 331

  2. Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Feng Peng, Gang Wu, Nong Xu, Lin Zhao, Dong Ma, Shukui Qin, Wei Ren, Enxiao Li, Hongda Lu, Yueyin Pan, Jianping Xiong, Ying Yuan, Yuxian Bai, Lei Chen, Yi Hu, Li Zhang, Yong Gao - The Lancet Oncology 2020 cited by 584

  3. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice

    Authors: , , , , , , , , , , , - Acta Biomaterialia 2020 cited by 149

  4. Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma

    Authors: , , , , , , , , , , , - Bioactive Materials 2021 cited by 125

  5. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery

    Authors: , , , , , , , , , , - Journal of Nanobiotechnology 2021 cited by 78

  6. Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 360

  7. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

    Authors: , , , , , , , , - Hepatology 2003 cited by 931

  8. Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 190

  9. Recent Advances in Strategies to Combat Bacterial Drug Resistance: Antimicrobial Materials and Drug Delivery Systems

    Authors: , , , , , , , - Pharmaceutics 2023 cited by 66

  10. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma

    Authors: , , , , , , , , , , , , , , , , - ACS Applied Materials & Interfaces 2018 cited by 160

  11. Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease

    Authors: , , , , , , - International Journal of Molecular Medicine 2018 cited by 130

  12. RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery

    Authors: , , , , , , , , , , , , - Journal of Controlled Release 2021 cited by 87

  13. Pd/IPrBIDEA-Catalyzed Hydrodefluorination of gem-Difluorocyclopropanes: Regioselective Synthesis of Terminal Fluoroalkenes

    Authors: , , , , , - Journal of the American Chemical Society 2023 cited by 70

  14. Cadmium Exposure and Liver Disease among US Adults

    Authors: , , , , , , , , - Journal of Gastrointestinal Surgery 2013 cited by 281

  15. Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 189

  16. Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post–Liver Transplant Score

    Authors: , , , , , , , , , , , , , , , , - Hepatology 2018 cited by 165

  17. Catalytic Diversification of gem‐Difluorocyclopropanes: Recent Advances and Challenges

    Authors: , , - ChemCatChem 2022 cited by 79

  18. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury

    Authors: , , , , , - Hepatology 2007 cited by 195

  19. Targeted delivery of PARP inhibitors to neuronal mitochondria via biomimetic engineered nanosystems in a mouse model of traumatic brain injury

    Authors: , , , , , , , , , , , , , - Acta Biomaterialia 2021 cited by 52

  20. Integrated Molecular Characterization of Fumarate Hydratase–deficient Renal Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yahong Chen, Qiang Wei, Xiang Li, Qiao Zhou, Haojie Huang, Jin Yao, Ni Chen, Hao Zeng - Clinical Cancer Research 2021 cited by 106

  21. Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways

    Authors: , , , , , , , , , , , , , , , - Redox Biology 2016 cited by 185

  22. Chemo‐, Stereo‐ and Regioselective Fluoroallylation/Annulation of Hydrazones with gem‐Difluorocyclopropanes via Tunable Palladium/NHC Catalysis

    Authors: , , , , - Angewandte Chemie International Edition 2023 cited by 61

  23. Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minggui Wang, Rui Wang, Aidong Wen, Jiuhong Wu, Xinan Wu, Yingchun Xu, Yong Yang, Fan Yang, Siyan Zhan, Bikui Zhang, Chao Zhang, Huizhi Zhang, Jie Zhang, Jing Zhang, Jun Zhang, Wenting Zhang, Libo Zhao, Limei Zhao, Rongsheng Zhao, Wei Zhao, Zhigang Zhao, Wei Zhou, Xian‐Tao Zeng, Suodi Zhai - Clinical Infectious Diseases 2020 cited by 168

  24. Intuitive Label-Free SERS Detection of Bacteria Using Aptamer-Based in Situ Silver Nanoparticles Synthesis

    Authors: , , , , , , , , , , , - Analytical Chemistry 2017 cited by 149